These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1255 related articles for article (PubMed ID: 22968073)

  • 1. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
    Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
    Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Margin status impacts survival after pancreaticoduodenectomy but negative margins should not be pursued.
    Mathur A; Ross SB; Luberice K; Kurian T; Vice M; Toomey P; Rosemurgy AS
    Am Surg; 2014 Apr; 80(4):353-60. PubMed ID: 24887665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival and quality of life in patients undergoing R1 pancreatic resection compared to patients with locally advanced unresectable pancreatic adenocarcinoma.
    Nordby T; Ikdahl T; Bowitz Lothe IM; Fagerland MW; Heiberg T; Hauge T; Labori KJ; Buanes T
    Pancreatology; 2013; 13(2):180-5. PubMed ID: 23561977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer.
    Strobel O; Berens V; Hinz U; Hartwig W; Hackert T; Bergmann F; Debus J; Jäger D; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S33-42. PubMed ID: 22770956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer?
    Amano H; Miura F; Toyota N; Wada K; Katoh K; Hayano K; Kadowaki S; Shibuya M; Maeno S; Eguchi T; Takada T; Asano T
    J Hepatobiliary Pancreat Surg; 2009; 16(6):850-7. PubMed ID: 19844653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.
    Kooby DA; Lad NL; Squires MH; Maithel SK; Sarmiento JM; Staley CA; Adsay NV; El-Rayes BF; Weber SM; Winslow ER; Cho CS; Zavala KA; Bentrem DJ; Knab M; Ahmad SA; Abbott DE; Sutton JM; Kim HJ; Yeh JJ; Aufforth R; Scoggins CR; Martin RC; Parikh AA; Robinson J; Hashim YM; Fields RC; Hawkins WG; Merchant NB
    Ann Surg; 2014 Sep; 260(3):494-501; discussion 501-3. PubMed ID: 25115425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival.
    Fatima J; Schnelldorfer T; Barton J; Wood CM; Wiste HJ; Smyrk TC; Zhang L; Sarr MG; Nagorney DM; Farnell MB
    Arch Surg; 2010 Feb; 145(2):167-72. PubMed ID: 20157085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.
    Strobel O; Hartwig W; Hackert T; Hinz U; Berens V; Grenacher L; Bergmann F; Debus J; Jäger D; Büchler M; Werner J
    Ann Surg Oncol; 2013 Mar; 20(3):964-72. PubMed ID: 23233235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Klaiber U; Schnaidt ES; Hinz U; Gaida MM; Heger U; Hank T; Strobel O; Neoptolemos JP; Mihaljevic AL; Büchler MW; Hackert T
    Ann Surg; 2021 Jan; 273(1):154-162. PubMed ID: 30921051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy.
    Kato K; Kondo S; Hirano S; Tanaka E; Shichinohe T; Tsuchikawa T; Matsumoto J
    J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):712-6. PubMed ID: 21455748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study.
    Yamamoto T; Satoi S; Kawai M; Motoi F; Sho M; Uemura KI; Matsumoto I; Honda G; Okada KI; Akahori T; Toyama H; Kurata M; Yanagimoto H; Yamaue H; Unno M; Kon M; Murakami Y
    Pancreatology; 2018 Jan; 18(1):106-113. PubMed ID: 29153701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.
    Demir IE; Jäger C; Schlitter AM; Konukiewitz B; Stecher L; Schorn S; Tieftrunk E; Scheufele F; Calavrezos L; Schirren R; Esposito I; Weichert W; Friess H; Ceyhan GO
    Ann Surg; 2018 Dec; 268(6):1058-1068. PubMed ID: 28692477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
    Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
    Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frozen section of the pancreatic neck margin in pancreatoduodenectomy for pancreatic adenocarcinoma is of limited utility.
    Pang TC; Wilson O; Argueta MA; Hugh TJ; Chou A; Samra JS; Gill AJ
    Pathology; 2014 Apr; 46(3):188-92. PubMed ID: 24614707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials.
    Butturini G; Stocken DD; Wente MN; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Dervenis C; Bassi C; Büchler MW; Neoptolemos JP;
    Arch Surg; 2008 Jan; 143(1):75-83; discussion 83. PubMed ID: 18209156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer.
    Kimbrough CW; St Hill CR; Martin RC; McMasters KM; Scoggins CR
    J Surg Oncol; 2013 May; 107(6):602-7. PubMed ID: 23450687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.